Previously, we reported that novel 2-hydroxydiarylamide derivatives inhibited TMPRSS4 serine protease activity and efficiently suppressed invasion of colon cancer cells overexpressing TMPRSS414. Here, TMPRSS4 is linked to colonic neoplasm.